Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Regulators split on gene therapy as patient shows signs of cancer

Nature volume 419, pages 545–546 (2002)Cite this article

Washington

The revelation last week that experimental gene therapy may have given a child a cancer-like illness has provoked diverse regulatory responses around the world.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Erika Check
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Check, E. Regulators split on gene therapy as patient shows signs of cancer. Nature 419, 545–546 (2002). https://doi.org/10.1038/419545a

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/419545a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing